Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex N Bullock

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Molecules (Basel, Switzerland)|July 24, 2021
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM FamilyOlivier E Nonga, Darja Lavogina, Erki Enkvist, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Structure (London, England : 1993)|March 13, 2009
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylationAlex N Bullock, Sanjan Das, Judit E Debreczeni, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
Plos One|May 7, 2013
A new class of small molecule inhibitor of BMP signalingCaroline E Sanvitale, Georgina Kerr, Apirat Chaikuad, et al.
The Journal of Experimental Medicine|August 19, 2009
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migrationRebekka Grundler, Laurent Brault, Christelle Gasser, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Plos One|August 31, 2013
Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1Edmond M Linossi, Indu R Chandrashekaran, Tatiana B Kolesnik, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Molecules (Basel, Switzerland)|July 24, 2021
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM FamilyOlivier E Nonga, Darja Lavogina, Erki Enkvist, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Structure (London, England : 1993)|March 13, 2009
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylationAlex N Bullock, Sanjan Das, Judit E Debreczeni, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
Plos One|May 7, 2013
A new class of small molecule inhibitor of BMP signalingCaroline E Sanvitale, Georgina Kerr, Apirat Chaikuad, et al.
The Journal of Experimental Medicine|August 19, 2009
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migrationRebekka Grundler, Laurent Brault, Christelle Gasser, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Plos One|August 31, 2013
Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1Edmond M Linossi, Indu R Chandrashekaran, Tatiana B Kolesnik, et al.
Pageof 12